These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8748884)

  • 1. Cellular basis of inflammation, edema and the activity of Daflon 500 mg.
    Friesenecker B; Tsai AG; Intaglietta M
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():17-21. PubMed ID: 8748884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch.
    Bouskela E; Donyo KA
    Angiology; 1997 May; 48(5):391-9. PubMed ID: 9158383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the phlebotropic drug Daflon 500 mg on postischemic microvascular disturbances in striated skin muscle: an intravital microscopic study in the hamster.
    Nolte D; Pickelmann S; Möllmann M; Schütze E; Kübler W; Leiderer R; Messmer K
    J Lab Clin Med; 1999 Nov; 134(5):526-35. PubMed ID: 10560947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From symptoms to leg edema: efficacy of Daflon 500 mg.
    Nicolaides AN
    Angiology; 2003; 54 Suppl 1():S33-44. PubMed ID: 12934755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Daflon 500mg on postischemic macromolecular leak syndrome in striated skin muscle of the hamster.
    Nolte D; Pickelman S; Schütze E; Möllmann M; Messmer K
    Int J Microcirc Clin Exp; 1997; 17 Suppl 1():6-10. PubMed ID: 9477038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: in vivo observations in the hamster skin fold.
    Friesenecker B; Tsai AG; Allegra C; Intaglietta M
    Int J Microcirc Clin Exp; 1994; 14(1-2):50-5. PubMed ID: 7960444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An original microhaemorheological approach to the pharmacological effects of Daflon 500 mg in severe chronic venous insufficiency.
    Allegra C; Bartolo M; Carioti B; Cassiani D
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():50-4. PubMed ID: 8748890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in diabetic hamsters.
    Bouskela E; Donyo KA
    Int J Microcirc Clin Exp; 1995; 15(6):293-300. PubMed ID: 8721438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postischemic leukocyte/endothelial cell interactions and microvascular barrier dysfunction in skeletal muscle: cellular mechanisms and effect of Daflon 500 mg.
    Korthuis RJ; Gute DC
    Int J Microcirc Clin Exp; 1997; 17 Suppl 1():11-7. PubMed ID: 9477039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the phlebotropic drug Daflon 500 mg on postischemic reperfusion injury in striated skin muscle: a histomorphologic study in the hamster.
    Pickelmann S; Nolte D; Leiderer R; Möllmann M; Schütze E; Messmer K
    J Lab Clin Med; 1999 Nov; 134(5):536-45. PubMed ID: 10560948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
    Struckmann JR; Nicolaides AN
    Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
    Geroulakos G; Nicolaides AN
    Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Daflon 500 mg, a flavonoid drug, on neurological signs, levels of free radicals and electroretinogram in the gerbil after ischemia-reperfusion injury.
    Delbarre B; Delbarre G; Calinon F
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():27-33. PubMed ID: 8748886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation.
    Paysant J; Sansilvestri-Morel P; Bouskela E; Verbeuren TJ
    Int Angiol; 2008 Feb; 27(1):81-5. PubMed ID: 18277344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser Doppler and transcutaneous oximetry: modern investigations to assess drug efficacy in chronic venous insufficiency.
    Belcaro G; Cesarone MR; de Sanctis MT; Incandela L; Laurora G; Février B; Wargon C; De Gregoris P
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():45-9. PubMed ID: 8748889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators involved in inflammation: effects of Daflon 500 mg on their release.
    Jean T; Bodinier MC
    Angiology; 1994 Jun; 45(6 Pt 2):554-9. PubMed ID: 8203787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic properties of Daflon 500 mg.
    Labrid C
    Angiology; 1994 Jun; 45(6 Pt 2):524-30. PubMed ID: 8203782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory reaction during venous hypertension in the rat.
    Takase S; Lerond L; Bergan JJ; Schmid-Schönbein GW
    Microcirculation; 2000 Feb; 7(1):41-52. PubMed ID: 10708336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized controlled trial of a micronized flavonidic fraction to reduce bleeding after haemorrhoidectomy.
    Ho YH; Foo CL; Seow-Choen F; Goh HS
    Br J Surg; 1995 Aug; 82(8):1034-5. PubMed ID: 7648143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.